Switch to:
PDL BioPharma Inc  (NAS:PDLI) Enterprise Value: $343.3 Mil (As of Today)

Think of enterprise value as the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents.

EV-to-EBIT is calculated as enterprise value divided by its EBIT. As of today, PDL BioPharma Inc's enterprise value is $343.3 Mil. PDL BioPharma Inc's EBIT for the trailing twelve months (TTM) ended in Jun. 2017 was $161.0 Mil. Therefore, PDL BioPharma Inc's EV/EBIT ratio for today is 2.13.

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PDL BioPharma Inc's enterprise value is $343.3 Mil. PDL BioPharma Inc's EBITDA for the trailing twelve months (TTM) ended in Jun. 2017 was $185.2 Mil. Therefore, PDL BioPharma Inc's EV/EBITDA ratio for today is 1.85.

EV-to-Revenue is calculated as enterprise value divided by its Revenue. As of today, PDL BioPharma Inc's enterprise value is $343.3 Mil. PDL BioPharma Inc's Revenue for the trailing twelve months (TTM) ended in Jun. 2017 was $309.4 Mil. Therefore, PDL BioPharma Inc's EV/Revenue ratio for today is 1.11.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

PDL BioPharma Inc Annual Data

Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Enterprise Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,145.60 1,476.83 1,408.52 615.06 345.53

PDL BioPharma Inc Quarterly Data

Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Enterprise Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 636.79 604.10 345.53 201.68 183.09

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents.

PDL BioPharma Inc's Enterprise Value for the fiscal year that ended in Dec. 2016 is calculated as

Enterprise Value (A: Dec. 2016 )
=Market Cap (M)+Preferred Stock+Long-Term Debt & Capital Lease Obligation
=350.9448+0+232.443
+Current Portion of Long-Term Debt+Minority Interest-Cash And Cash Equivalents
+0+4.28-242.141
=345.5

PDL BioPharma Inc's Enterprise Value for the quarter that ended in Jun. 2017 is calculated as

Enterprise Value (Q: Jun. 2017 )
=Market Cap (M)+Preferred Stock+Long-Term Debt & Capital Lease Obligation
=380.5776+0+114.044
+Current Portion of Long-Term Debt+Minority Interest-Cash And Cash Equivalents
+123.793+0-435.323
=183.1

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap (M) because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of enterprise value.

For the companies with the same Market Cap (M), the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap (M). In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as enterprise value divided by its EBIT.

PDL BioPharma Inc's EV/EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=343.334/161.024
=2.13

PDL BioPharma Inc's current Enterprise Value is $343.3 Mil.
PDL BioPharma Inc's EBIT for the trailing twelve months (TTM) ended in Jun. 2017 was 32.817 (Sep. 2016 ) + -9.837 (Dec. 2016 ) + 18.717 (Mar. 2017 ) + 119.327 (Jun. 2017 ) = $161.0 Mil.

2. EV-to-EBITDA is calculated as enterprise value divided by its EBITDA.

PDL BioPharma Inc's EV/EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=343.334/185.232
=1.85

PDL BioPharma Inc's current Enterprise Value is $343.3 Mil.
PDL BioPharma Inc's EBITDA for the trailing twelve months (TTM) ended in Jun. 2017 was 38.847 (Sep. 2016 ) + -3.823 (Dec. 2016 ) + 24.732 (Mar. 2017 ) + 125.476 (Jun. 2017 ) = $185.2 Mil.

3. EV-to-Revenue is calculated as enterprise value divided by its Revenue.

PDL BioPharma Inc's EV/Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=343.334/309.405
=1.11

PDL BioPharma Inc's current Enterprise Value is $343.3 Mil.
PDL BioPharma Inc's EBITDA for the trailing twelve months (TTM) ended in Jun. 2017 was 53.638 (Sep. 2016 ) + 66.492 (Dec. 2016 ) + 45.44 (Mar. 2017 ) + 143.835 (Jun. 2017 ) = $309.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Related Terms


Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK